Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-H0731 Intensification in Chronic Hepatitis B
NCT04454567Phase 2Terminated
- Sponsor
- Assembly Biosciences, Inc.
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vebicorvir in Chronic Hepatitis B (CHB), sponsored by Assembly Biosciences, Inc.. Started Nov 2020; status: terminated.
02
Drugs
vebicorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04454567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454567.